BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37481449)

  • 1. [Intraocular pressure elevation and intravitreal steroid implant injection: State of the art in 2023. Recommendations of the French Glaucoma Society and French Ophthalmology Society [French version]].
    Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
    J Fr Ophtalmol; 2023 Sep; 46(7):803-810. PubMed ID: 37481449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.
    Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
    J Fr Ophtalmol; 2023 Oct; 46(8):e249-e256. PubMed ID: 37302867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of selective laser trabeculoplasty as an alternative in patients who developed ocular hypertension after intravitreal dexamethasone implants: a series of 35 eyes.
    Billant J; Agard E; Douma I; Levron A; Brunet O; Remignon CH; Sejournet L; Dot C
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3665-3673. PubMed ID: 35665853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
    Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
    J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
    Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
    Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
    Polski A; Liu KC; Gupta D; Grewal DS; Horns J; Wirostko BM; Stagg BC
    BMJ Open Ophthalmol; 2023 Dec; 8(1):. PubMed ID: 38135349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
    Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
    Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
    Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
    Dot C; El Chehab H; Russo A; Agard E
    J Fr Ophtalmol; 2015 Sep; 38(7):656-64. PubMed ID: 26099427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study.
    Rousseau N; Lebreton O; Masse H; Maucourant Y; Pipelart V; Clement M; Le Lez ML; Khanna RK; Pepin M; Eude Y; Le Meur G; Weber M; Ducloyer JB
    Ophthalmol Ther; 2023 Oct; 12(5):2781-2792. PubMed ID: 37369907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
    Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
    Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant.
    Baillif S; Staccini P; Weber M; Delyfer MN; Le Mer Y; Gualino V; Collot L; Merite PY; Creuzot-Garcher C; Kodjikian L; Massin P
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
    Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
    Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
    Chang IT; Gupta D; Slabaugh MA; Vemulakonda GA; Chen PP
    J Glaucoma; 2016 Oct; 25(10):842-846. PubMed ID: 27300641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
    Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
    Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
    Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
    Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.